Literature DB >> 679504

Bromocriptine treatment of males with pituitary tumours, hyperprolactinaemia, and hypogonadism.

M Nagulesparen, V Ang, J S Jenkins.   

Abstract

Plasma prolactin concentrations were measured in thirty-four males with pituitary tumours and twenty-two patients (65%) were found to have hyperprolactinaemia. Plasma testosterone concentrations were subnormal in twenty-nine patients. Ten patients with hyperprolactinaemia were treated with bromocriptine; prolactin was restored to normal values in eight patients but testosterone secretion remained deficient. Two patients were resistant to bromocriptine. Some improvement in libido and potency was obtained after restoration of normal prolactin concentrations in four cases in spite of persistently low testosterone secretion. For maximal improvement in sexual function treatment with both bromocriptine and testosterone was required.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679504     DOI: 10.1111/j.1365-2265.1978.tb03574.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma).

Authors:  M Berezin; I Shimon; M Hadani
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

2.  Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment.

Authors:  O Serri; M Somma; E Rasio; H Beauregard; J Hardy
Journal:  Can Med Assoc J       Date:  1980-05-10       Impact factor: 8.262

3.  Hypothalamic-pituitary-testicular function in men with PRL-secreting tumors.

Authors:  B Ambrosi; M Gaggini; P Travaglini; P Moriondo; R Elli; G Faglia
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

4.  Sexual function in women with hypothalamo-pituitary disorders.

Authors:  B Hulter; P O Lundberg
Journal:  Arch Sex Behav       Date:  1994-04

5.  Hyperprolactinaemia in male diabetics.

Authors:  A D Mooradian; J E Morley; C J Billington; M F Slag; M K Elson; R B Shafer
Journal:  Postgrad Med J       Date:  1985-01       Impact factor: 2.401

Review 6.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.